Skip to main content
. 2024 Apr 19;13:e89157. doi: 10.7554/eLife.89157

Figure 2. Survival of rBCG::iE-DAP in IFNγ activated bone marrow derived macrophages (BMDMs), training of monocytes and activation with doxycycline.

(A) IFNγ-activated BMDMs (1x106 cells) were infected at MOI: 1 with WT BCG and rBCG::iE-DAP. ATc was added to culture media for induction of the CRISPRi system in rBCG::iE-DAP at concentrations ranging from 100 ng/ml – 500 ng/ml and growth of the strains was assessed after 3 and 5 days. (B) Training of U937 monocytes with heat-killed (HK)-rBCG::iE-DAP compared to HK-WT BCG. Shown is also the representative plates for the experiment. (C, D) CFU counts of in vitro grown WT BCG and of rBCG::iE-DAP grown in complete 7H9 medium at varying concentrations of Dox. (E) Determination of the Dox concentration for activation of rBCG::iE-DAP in vivo. Mice were aerosol infected with ~2.5 log10 CFU of rBCG and Dox (0.125–1 mg/kg/day) - was administered by oral gavage for 10 days. (F, G) CFU counts from the experiment shown in panel E. Lung homogenates were plated on both 7H11 with (G) and without (F) kanamycin (25 µg/ml) to assess the loss of the CRISPRi plasmid during in vivo growth. p-values are given above the graphs. (H) Aerosol infection of mice with ~2.5 log10 CFU of WT BCG, rBCG::iE-DAP and administration of Dox (1 mg/kg/day) for 8 weeks. (I) Plates showing the colony size of rBCG::iE-DAP+Dox compared to WT BCG or WT BCG+Dox, recovered from the lungs of aerosol infected mice from the experiment shown in panel H. Three independent biological repeats (n=3) were assessed for the in vitro experiments, the error bars represent the standard deviation relative to the mean. Five mice per group (n=5) were used for the in vivo experiments. Student t-test was used for statistical analysis. The error bars represent the standard deviation relative to the mean. *: p-value <0.05.

Figure 2—source data 1. Activation of rBCG::iE-DAP in BMDMs, training of monocytes and activation with doxycycline.

Figure 2.

Figure 2—figure supplement 1. Analysis of secreted TNFα levels from non-activated and IFN-activated BMDMs infected with WT BCG and rBCG::iE-DAP at MOI 1:20.

Figure 2—figure supplement 1.

Increased TNF secretion was observed from rBCG::iE-DAP infected IFN-activated BMDMs cultured in media supplemented with 500 ng/ml ATc. LPS was used as a control. Three independent biological repeats (n=3) were assessed. Student t-test was used for statistical analysis. The error bars represent the standard deviation relative to the mean *: p-value <0.01.
Figure 2—figure supplement 1—source data 1. TNFα ELISA of non-activated and IFNγ-activated BMDMs infected with WT BCG and rBCG:: iE-DAP.
Figure 2—figure supplement 2. Efficacy of 1 mg/kg/day dose of doxycycline for CRISPRi activation.

Figure 2—figure supplement 2.

(A) Schematic representation of mice aerosol infection with WT BCG and rBCG::iE-DAP and analysis of the efficacy of 1 mg/kg/day dose of doxycycline for CRISPRi-MurT-GatD activation in vivo. (B) Day 1 implantation of WT BCG and rBCG::iE-DAP in the lungs of aerosol infected mice. (C) Day 28 bacterial loads of WT BCG and rBCG::iE-DAP aerosol infected mice. (D) PCR amplification of dCas9 in recovered Big (BC) or Small (SC) rBCG::iE-DAP colonies. Lane 1 is 1 kb plus DNA molecular weight marker. (E, F) Growth kinetics of big and small colonies of rBCG::iE-DAP vs WT BCG in liquid broth supplemented with Doxycycline. Three independent biological repeats (n=3) were assessed for the in vitro experiment. Five mice per group (n=5) were used for the in vivo experiments. Statistical analysis was conducted using student t-test. The error bars represent the standard deviation relative to the mean. *: p-value:<0.01.
Figure 2—figure supplement 2—source data 1. Efficacy of 1 mg/kg/day dose of doxycycline for CRISPRi Figure 2—figure supplement 2d activation.